– B-SIMPLE4 pivotal Phase 3 trial evaluating SB206 as a treatment for molluscum contagiosum progressing with top-line efficacy results targeted before the end of Q2 2021 – – Company targeting initiating preclinical studies for intranasal formulation of …
BALTIMORE, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Laureate Education, Inc. (NASDAQ: LAUR) today announced financial results for the fourth quarter and the year ended December 31, 2020. Unless indicated otherwise, the results presented below relate to Continuing …
- Outlined strategy to build integrated cell therapy company and the Company’s “2-2-5-2” five-year core value drivers - - Reported compelling durable responses in patients with synovial sarcoma, and initial responses in lung, head and neck, liver, …
SAN DIEGO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that management will participate in three upcoming virtual …
VANCOUVER, British Columbia, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Osino Resources Corp. (TSXV: OSI) (FSE: RSR1) (OTCQB: OSIIF) (“Osino” or “the Company”) is pleased to announce that management will be participating in the 30th annual BMO Global Metals & …
PHILADELPHIA, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, today …
Fourth Quarter 2020 Revenues of $626.6 Million, Up 4.0% Compared to $602.2 Million in Prior Year Quarter Fourth Quarter 2020 EPS of $1.57, Up 106.6% Compared to $0.76 in Prior Year Quarter; Fourth Quarter 2020 Adjusted EPS of $1.61, Up 101.3% Compared to $ …
MONTREAL, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced its financial …
SAN MATEO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”), a cannabis and hemp branded products company in the U.S., is pleased to announce today that, further to its press release dated …
Successfully launched CAPLYTA® (lumateperone) in late March 2020 and demonstrated strong commercial execution in the midst of COVID-19. CAPLYTA achieved net product revenues of $12.4 million and $22.5 million for fourth quarter and full year 2020, …
Expects to report initial data from Phase 1 study of NTLA-2001, a potentially curative single-course therapy for transthyretin amyloidosis (ATTR), in 2021 On track to submit an IND or IND-equivalent in mid-2021 for NTLA-5001 for the treatment of acute …
ATLANTA, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Gray Television, Inc. (“Gray,” “we,” “us” or “our”) (NYSE: GTN) announced today that its Board of Directors has authorized the initiation of a regular quarterly cash dividend of $0.08 per share of its common stock …
BOSTON, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Today, DraftKings (Nasdaq: DKNG) announced the appointment of baseball legend and entrepreneur Cal Ripken Jr. as a special advisor to the board of directors. Ripken will lend strategic insights to the board of …
DUBLIN, Ireland and TREVOSE, Pa., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with …
–Completed acquisition of Eidos Therapeutics, allowing BridgeBio to deploy its full clinical and commercial infrastructure to develop and plan for potential global commercialization upon regulatory approval of Eidos’ product candidate, acoramidis, a …
Reaffirms plans to resubmit its New Drug Application (NDA) around the end of second quarter 2021 Received additional feedback from FDA after completion of Type A meeting and submission of revised weight based dosing regimen Anticipates an FDA action date …
WILLIAMSVILLE, N.Y., Feb. 25, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, will host …
Fourth Quarter Revenue Grew 17.5% Year-Over-Year Full Year 2020 Revenue Grew 25.6% Year-Over-Year Completed $2.16 billion Initial Public Offering HERZLIYA, Israel, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Playtika Holding Corp. (NASDAQ: PLTK) today released …
Full year consolidated sales increased 9.0% from prior year period Full year operating income increased 14.8%; Adjusted operating income up 20.9% ATCHISON, Kan., Feb. 25, 2021 (GLOBE NEWSWIRE) -- MGP Ingredients, Inc. (Nasdaq:MGPI), a leading supplier of …
VANCOUVER, British Columbia, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Vinergy Cannabis Capital, Inc. ("Vinergy" or the "Company") (CSE:VIN, OTCQB:VNNYF, FSE:1V7) announces that the Company has appointed Mr.Albert Szmigielski as an Advisor to …
01 days 09:22:02
